Translating clinical trial results into practice: The effect of an AIDS Clinical Trial on prescribed antiretroviral therapy for HIV-infected pregnant women

Annals of Internal Medicine

Volumn 130, Issue 12, 1999, Pages 979-986

  Turner, Barbara J ^a   Newschaffer, Craig J ^a   Zhang, Daozhi ^a   Fanning, Thomas ^b   Hauck, Walter W ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL PROTOCOL; COMORBIDITY; DRUG SAFETY; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PLACENTAL TRANSFER; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT PLANNING; VIRUS TRANSMISSION;

EID: 0033564516     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-130-12-199906150-00005     Document Type: Article

References (38)

1. Psaty BM, Koepsell TD, Yanez ND, Smith NL, Manolio TA, Heckbert SR, et al. Temporal patterns of antihypertensire medication use among older adults, 1989 through 1992. An effect of the major clinical trials on clinical practice? JAMA. 1995;273:1436-8.
2. Iscoe NA, Naylor CD, Williams JI, DeBoer G, Morgan MW, Fehringer G, et al. Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference? CMAJ. 1994;150:1109-15.
3. Ketley D, Woods KL. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet. 1993;342:891-4.
4. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173-80.
5. Cotton P. Trial halted after drug cuts maternal HIV transmission rate by two thirds [News], JAMA. 1994;271:807.
6. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1994;43:1-20.
7. Healton C, Taylor S, Burr C, Dumois A, Loewenstein N, Kaye J. The impact of patient education about the effect of zidovudine on HIV perinatal transmission: knowledge gain, attitudes, and behavioral intent among women with and at risk of HIV. Am J Prev Med. 1996; 12(4 Suppl):47-52.
8. Designated care programs for patients with AIDS and HIV related illnesses in designated care centers. N Y State J Med. 1989;89:542-3.
9. State of New York Department of Health Memorandum. Health Facilities Series: H-23, D&TC-17, HMO-16, 93-26. 3 November 1993.
10. Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med. 1995;334:701-6.
11. Laine C, Markson LE, McKee LJ, Hauck WW, Fanning TR, Turner BJ. The relationship of clinic experience with advanced HIV and survival of women with AIDS. AIDS. 1998;12:417-24.
12. Turner BJ, Markson L. Cocroft J, Cosler L, Hauck WW. Clinic HIV-focused features and prevention of Pneumocystis carinii pneumonia. J Gen Intern Med. 1998;13:16-23.
13. Codes, Rules, and Regulations of New York State. Prenatal Care Assistance Program. New York State Public Health Law 10NYCRR Part 85.40.
14. Turner BJ, Markson L, Hauck W, Cocroft J, Fanning T. Prenatal care of HIV-infected women: analysis of a large New York State cohort. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:371-8.
15. Turner BJ, McKee L, Silverman NS, Hauck WW, Fanning TR, Markson LE. Prenatal care and birth outcomes of a cohort of HIV-infected women. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:259-67.
16. Turner BJ, Hauck WW, Fanning TR, Markson LE. Cigarette smoking and maternal-child HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:327-37.
17. Fanning TR, Turner BJ, Cosler LE, Oetjen-Gerdes L. Markson LE, McKee L, et al. Quality of Medicaid data for HIV/AIDS research: examination of a statewide database. AIDS & Public Policy Journal. 1995;10:39-47.
18. Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index. Am J Public Health. 1994;84:1414-20.
19. American Public Health Association Meeting. Adequacy of prenatal care: vital statistics vs. Medicaid claims data. Washington, DC: American Public Health Association; 1998.
20. McDermott J, Drews C, Green D, Berg C. Evaluation of prenatal care information on birth certificates. Paediatr Perinat Epidemiol. 1997;11:105-21.
21. Gwinn M. Mel JV, Sprulll CL, Dobbs TL, Hannon WH, LaLota M. Hospital variation in intrapartum use of zidovidine [Letter], JAMA. 1997;277: 299.
22. Fiscus SA, Adimora AA, Schoenbach VJ, Lim W, McKinney R, Rupar D, et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA. 1996;275:1483-8.
23. Wiznia AA, Crane M, Lambert G, Sansary J, Harris A, Solomon L. Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center. JAMA. 1996;275:1504-6.
24. Wortley PM, Chu SY, Diaz T, Ward JW, Doyle B, Davidson AJ, et al. HIV testing patterns: where, why, and when were persons with AIDS tested for HIV? AIDS. 1995;9:487-92.
25. Phillips KA, Morrison KR, Sonnad SS, Bleecker T. HIV counseling and testing of pregnant women and women of childbearing age by primary care providers: self-reported beliefs and practices. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:174-8.
26. Success in implementing Public Health Service guidelines to reduce perinatal transmission of HIV - Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and 1996. MMWR Morb Mortal Wkly Rep. 1998;47:688-91
27. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. 1. Treatments following myocardial infarction. JAMA. 1988;260:2088-93.
28. Bowker TJ, Clayton TC, Ingham J, McLennan NR, Hobson HL, Pykes D, et al. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart. 1996;75:334-42.
29. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM. Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ. 1998;316:1430-4.
30. Avanzini F, Zuanetti G, Latini R, Colombo F, Santoro E, Maggioni AP, et al. Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine? GISSI experience, 1984-1993. The Gruppo Italiano di Studio della Soprawivenza nell'Infarto Miocardio (GISSI) Investigators. Eur Heart J. 1997;18:1447-56.
31. Smith SC Jr. Risk reduction therapies for patients with coronary artery disease: a call for increased implementation. Am J Med. 1998;104:235-265.
32. Markson LE, Cosler LE, Turner BJ. Implications of generalists' slow adoption of zidovudine in clinical practice. Arch Intern Med. 1994;154:1497-504.
33. Cooper ER, Nugent RP, Diaz C, Pitt J, Hanson C, Kalish LA, et al. After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study Group. J Infect Dis. 1996;174:1207-11.
34. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8:261-9.
35. Bobat R, Coovadia H, Coutsoudis A, Moodley D. Determinants of mother-to-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South Africa. Pediatr Infect Dis J. 1996;15:604-10.
36. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood. 1998;91:301-8.
37. Saah AJ, Hoover DR, He Y, Kingsley LA, Phair JP. Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr. 1994;7:287-95.
38. Silverman NS, Rohner DM, Turner BJ. Attitudes toward health-care, HIV infection, and perinatal transmission interventions in a cohort of inner-city, pregnant women. Am J Perinatol. 1997;14:3416.